Journal Home
Search for

Volume 157, Issue 6, Pages 1010-1017 (June 2009)


View previous. 11 of 24 View next.

Influence of age on the management of heart failure: Findings from Get With the Guidelines–Heart Failure (GWTG-HF)

for the Get With the Guidelines Steering Committee and HospitalsDaniel E. Forman, MDabCorresponding Author Informationemail address, Christopher P. Cannon, MDa, Adrian F. Hernandez, MD, MHSc, Li Liang, PhDd, Clyde Yancy, MDe, Gregg C. Fonarow, MDf

Received 15 December 2008; accepted 4 March 2009. published online 27 April 2009.

Background

Heart failure (HF) is common among elderly adults. Although multiple studies demonstrate age-related declines in the utilization of evidence-based therapies for coronary artery disease, there are few analyses of HF patients to distinguish possible age-related management differences.

Methods

We analyzed 57,937 HF admissions from January 2005 through April 2007 in 257 hospitals participating in the American Heart Association's Get With The Guidelines–Heart Failure program. Patient characteristics and management were stratified by age groups ≤65, 66-75, 76-85, and >85 years. Multivariable regression analyses were used to assess the influence of age on use of therapies and inhospital mortality.

Results

The mean patient age was 73 ± 14 years; 18.7% were >85 years of age. Prescriptions of most HF therapies were relatively reduced with age but still remained high overall. Although 88.6% of patients ≤65 years of age with left ventricular systolic dysfunction were prescribed angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and 90.9% were prescribed β-blockers, among those >85 years of age with left ventricular systolic dysfunction, 79% were prescribed angiotensin-converting enzyme inhibitor or angiotensin receptor blocker and 82.7% were prescribed β-blockers. Regression analysis that accounted for typical confounders demonstrated that older age was associated with diminished utilization of most evidence-based treatment measures as well as increased mortality.

Conclusions

Get With The Guidelines–Heart Failure data demonstrate that guidelines recommended therapies are frequently utilized for older patients with HF, including patients >85 years old. Nonetheless, age-related differences in therapy persist, suggesting that opportunities to improve care still remain.

a Cardiovascular Division, Brigham and Women's Hospital, Boston, MA

b VA Boston Healthcare System, Boston, MA

c Cardiovascular Medicine, Duke University Medical Center, Durham, NC

d Duke Clinical Research Institute; Durham, NC

e Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX

f Ahmanson-UCLA Cardiomyopathy Center, University of California, Los Angeles, CA

Corresponding Author InformationReprint requests: Daniel E. Forman, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115.

 Dr. Mihai Gheorghiade served as guest editor on this manuscipt.

PII: S0002-8703(09)00204-X

doi:10.1016/j.ahj.2009.03.010


View previous. 11 of 24 View next.